- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04004390
Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin (PPS and IGIV)
Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin: a Retrospective Study of Efficacy on Clinical and Isokinetic Criteria
Study Overview
Status
Conditions
Detailed Description
Patients are admitted to a multidisciplinary consultation (neurologist, PMK) to validate the indication of treatment with IGIV. Realization of a pre-therapeutic evaluation in the department of MPR on the criteria of judgment, then the patient is admitted in a service of neurology to benefit from the cure of IGIV. The patient is then re-admitted to a PMR service for post-treatment evaluation.
Collection of data retrospectively.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34295
- UH Montpellier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of PPS
- Pre- and post-therapeutic evaluation carried out
- Data transcribed in the computerized patient file
Exclusion Criteria:
- No walking patient
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscular strength
Time Frame: 5 months
|
Muscular strength with isokinetic
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Walking perimeter
Time Frame: 5 months
|
Walking perimeter with walking test (6 minutes)
|
5 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: MOIZIARD Vincent, intern, University Hospital, Montpellier
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Central Nervous System Diseases
- Nervous System Diseases
- RNA Virus Infections
- Virus Diseases
- Infections
- Musculoskeletal Diseases
- Muscular Diseases
- Neuromuscular Diseases
- Central Nervous System Infections
- Neurodegenerative Diseases
- Enterovirus Infections
- Picornaviridae Infections
- Spinal Cord Diseases
- Muscular Disorders, Atrophic
- Myelitis
- Poliomyelitis
- Postpoliomyelitis Syndrome
Other Study ID Numbers
- RECHMPL19_0322
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-Poliomyélitis Syndrom
-
RWTH Aachen UniversityCompletedAcute Coronary Syndrom | Chronic Obstructive Pulmonary SyndromGermany
-
Union de Gestion des Etablissements des Caisses...RecruitingUpper Limb Exclusion SyndromFrance
-
CHU de ReimsCompletedNeurogenic Vesical Hyperactivity SyndromFrance
-
University Hospital RegensburgUniversity of MagdeburgTerminated
-
AstraZenecaCompleted
-
University Hospital, MontpellierUnknownHigh Flow Nasal Cannula | Respiratory Distress SyndromFrance
-
Nantes University HospitalRecruitingAcute Traumatic Cervical Central Cord Syndrom InjuryFrance
-
Quanta MedicalNAOS Institute of Life ScienceCompletedGrade 2 Hand-foot SyndromFrance
-
Boston Children's HospitalTerminatedPost-tonsillectomy Pain | Post-tonsillectomy Activity | Post-tonsillectomy HydrationUnited States
-
Centre Hospitalier Universitaire VaudoisCompletedPregnancy | Pregestational Diabetes | Polycystic Ovary Syndrom